As we had hoped, the United States Supreme Court agreed today to review the First Circuit's remarkable ruling in Mutual Pharmaceutical Co. v. Bartlett, that a state court plaintiff can argue that an FDA approved drug should be removed from the market altogether. The Supreme Court's order granting certiorari is here.